|
Rinko Ghosh joined Nektar in May 2001 and has more than 17 years of experience in pharmaceutical, biotechnology and related industries. His primary responsibilities at Nektar have included product and technology licensing, mergers and acquisitions, strategic planning, portfolio evaluation and alliance management. At Nektar he has been instrumental in closing large, revenue-generating transactions and building long-term, strategic partnerships with Bayer, Novartis, Baxter, Amgen, Roche, Pfizer, UCB and other major pharmaceutical companies.
Prior to joining Nektar, he was engaged as Commercial Development Consultant at Aviron (now MedImmune/Astra Zeneca) in Palo Alto, CA. Before Aviron, he was co-CEO of a biopharmaceutical startup in Asia. Earlier, he spent several years in healthcare and general management consulting at the San Francisco office of A.T. Kearney. Mr. Ghosh has been actively involved with non-profits, including the Asian Art Museum of San Francisco. He has served on several non-profit boards where has helped resolve issues related to board governance, general management and strategic planning.
Mr. Ghosh holds a M.B.A. degree from the Wharton School, University of Pennsylvania, a M.S. degree in Environmental Engineering from Vanderbilt University, and a B.S. degree in Chemical Engineering from the Indian Institute of Technology. | 